• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Butterfly IQ Expands Whole-Body Ultrasound System to Android Devices

Share:

December 31, 2019

Highlights on this story:
  • Butterfly iQ, the world’s first single-probe whole body ultrasound system announces it is now compatible with Android for the first time, allowing for even greater accessibility to medical professionals around the world
  • With this expansion, Butterfly’s mission to help pave the way for early detection and diagnosis of health issues globally has become even more tangible.
  • From remote villages in Africa to research missions in the arctic tundra, Butterfly is dedicated to providing a seamless and intuitive ultrasound experience to medical professionals across the globe, including over 2.5 million Android users.

Butterfly Network, Inc., the world’s first single-probe whole-body ultrasound system, announced its new expanded compatibility of Butterfly iQ with 10 Samsung and Google devices and additional financing options from Affirm Inc., further democratizing medical imaging availability. Since its introduction in 2018, Butterfly iQ has seen rapid adoption by tens of thousands of physicians, EMTs, physician assistants, nurses and other healthcare providers around the world.

Whole-Body Ultrasound System on Android Devices

Butterfly iQ’s single probe delivers a 2D array of 9000 micro-machined sensors emulating any type of transducer – linear, curved or phased. As the leading mobile operating system worldwide, Android’s reach will place the point of care ultrasound in the hands of an even wider audience, growing Butterfly iQ’s list of compatible devices to 9 Android phones and 1 tablet, with more devices and features to be added in the future.

– Samsung Galaxy (Model S10 SM-G973U, SM-G973U1)

– Samsung Galaxy S9 and S9+, and up

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Samsung Galaxy Tab S6

– Google Pixel 3 and 3XL, and up

Availability & Pricing

Ultrasound’s medical impact and global accessibility has been historically limited by the steep cost of traditional systems. Butterfly’s continued mission is to lower this barrier to entry. Through Affirm’s financial technology, which provides customers with a transparent payment alternative to cash and traditional credit, Butterfly Network is now offering ultrasound at a lower price than ever before, starting at $58/month.

Financing is available on 12-, 24- and 36-month terms with 0% APR for qualified practitioners and will only be applicable for initial purchase including a Butterfly iQ probe, with renewal fees charged at the end of the first year if there is no subscription pre-payment.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Why Healthcare Data Won’t Magically Create Value-Based CareWhy Healthcare Data Won’t Magically Create Value-Based Care
  • Healthline Acquires Healthy Living Property Greatist.comHealthline Acquires Healthy Living Property Greatist.com
  • Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private PlacementAadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
  • Ping An Researchers Develop AI-Powered Drug Discovery FrameworkPing An Researchers Develop AI-Powered Drug Discovery Framework
  • Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer ResearchAgilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
  • CareDx to Acquire Transplant Hero Medication Management AppCareDx to Acquire Transplant Hero Medication Management App
  • Center for Genomic Discovery Launched in the United Arab EmiratesCenter for Genomic Discovery Launched in the United Arab Emirates
  • Salveo Diagnostics Merges Two Local Companies Into Its Growing PortfolioSalveo Diagnostics Merges Two Local Companies Into Its Growing Portfolio

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications